United States · FDA National Drug Code directory
Cefprozil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-397_a623c2b2-f643-4ab4-aef5-60686abf7b88
- Product NDC
- 16714-397
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cefprozil
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070130
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFPROZIL — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 mL in 1 BOTTLE (16714-397-01) · 16714-397-01
- 75 mL in 1 BOTTLE (16714-397-02) · 16714-397-02
- 100 mL in 1 BOTTLE (16714-397-03) · 16714-397-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →